Trends in child and teen nonprescription drug abuse reported to a regional poison control center

American Journal of Health-System Pharmacy

Volumn 61, Issue 12, 2004, Pages 1252-1257

  Crouch, Barbara Insley ^a,b   Caravati, E Martin ^c,d   Booth, Jeremy ^e  

^a Utah Poison Control Center   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Department of Pharmacy Practice

^d UU   (Sweden)

^e BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Adolescents; Antitussives; Caffeine; Central nervous system stimulants; Dextromethorphan; Drug abuse; Drugs; Over the counter; Parasympatholytic agents; Pediatrics

Indexed keywords

ANALGESIC AGENT; ANTIHISTAMINIC AGENT; CAFFEINE; CENTRAL STIMULANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXTROMETHORPHAN; EPHEDRINE; GASTROINTESTINAL AGENT; NON PRESCRIPTION DRUG; PHENYLPROPANOLAMINE;

ADOLESCENT; ADULT; ANALGESIC AGENT ABUSE; CHILD; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; HEALTH CARE FACILITY; HUMAN; POISON CENTER; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

EID: 8344282023     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.12.1252     Document Type: Review

References (29)

1. Johnston LD, O'Malley PM, Bachman JG. Monitoring the Future: national results on adolescent drug use: overview of key findings, 2001. Bethesda, MD: U.S. Department of Health and Human Services, 2002; NIH publication no. 02-5105.
2. Grunbaum JA, Kann L, Kinchen SA et al. Youth risk behavior surveillance - United States, 2001. MMWR Surveill Summ. 2002; 51(4):1-64.
3. Epstein JF. Substance dependence, abuse, and treatment: findings from the 2000 National Household Survey on Drug Abuse. Rockville, MD: U.S. Department of Health and Human Services, 2002; DHHS publication no. SMA 02-3642 (Series A-16).
4. Litovitz TL, Klein-Schwartz W, White S et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2001; 19:337-95.
5. Bassett KE, Schunk JE, Crouch BI. Cyclizine abuse by teenagers in Utah. Am J Emerg Med. 1996; 14:472-4.
6. Banerji S, Anderson IB. Abuse of Coricidin HBP cough & cold tablets: episodes recorded by a poison center. Am J Health-Syst Pharm. 2001; 58:1811-4.
7. Wolfe TR, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med. 1995; 13:174-6.
8. The Vaults of Erowid. Documenting the complex relationship between humans and psychoactives. www.erowid.org (accessed 2004 Mar 12).
9. Goetz K. Kids abuse cough pills, officials say. http://enquirer.com/ editions/2000/ 02/18/loc_kids_abuse_cough.html (accessed 2002 Aug 30).
10. Baker SD, Borys DJ. A possible trend suggesting increased abuse from Coricidin exposures reported to the Texas Poison Network: comparing 1998 to 1999. Vet Hum Toxicol. 2002; 44:169-71.
11. Samenuk D, Link MS, Homoud MK et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc. 2002; 77:12-6.
12. Food and Drug Administration. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Fed Regist. 2004; 69:6787-854.
13. Rowe C, Verjee Z, Koren G. Adolescent dimenhydrinate abuse: resurgence of an old problem. J Adolesc Health. 1997; 21: 47-9.
14. Murray S, Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. South Med J. 1993; 86:1151-3.
15. Gott PH. Cyclizine toxicity - intentional drug abuse of a proprietary antihistamine. N Engl J Med. 1968; 279:596.
16. Cox D, Ahmed Z, McBride AJ. Diphenhydramine dependence. Addiction. 2001; 96:516-7. Letter.
17. Gardner DM, Kutcher S. Dimenhydrinate abuse among adolescents. Can J Psychiatry. 1993; 38:113-6.
18. Feldman MD, Behar M. A case of massive diphenhydramine abuse and withdrawal from use of the drug. JAMA. 1986; 255: 3119-20. Letter.
19. Dodds A, Revai E. Toxic psychosis due to dextromethorphan. Med J Aust. 1967; 2: 231. Letter.
20. Tinsley JA, Watkins DD. Over-the-counter stimulants: abuse and addiction. Mayo Clin Proc. 1998; 73:977-82.
21. Helfer J, Kim OM. Psychoactive abuse potential of Robitussin-DM. Am J Psychiatry. 1990; 147:672-3. Letter.
22. Fleming PM. Dependence on dextromethorphan hydrobromide. Br Med J. 1986; 293:597.
23. Ruben SM, McLean PC, Melville J. Cyclizine abuse among a group of opiate dependents receiving methadone. Br J Addict. 1989; 84:929-34.
24. Martin CE, Oglesbee FW. Television advertising and drug use. Am Pharm. 1983; NS23:44-5.
25. Kallir J. Drug advertising and drug abuse. Int Pharmacopsychiatry. 1972; 7:138-49.
26. 'Look-alikes.' Pediatrics. 1983; 72:256-7.
27. Blum A. Phenylpropanolamine: an over-the-counter amphetamine? JAMA. 1981; 245:1346-7. Editorial.
28. MacFadyen L, Eadie D, McGowan T. Community pharmacists' experience of over-the-counter medicine misuse in Scotland. J R Soc Health. 2001; 121:185-92.
29. Hughes GF, McElnay JC, Hughes CM et al. Abuse/misuse of non-prescription drugs. Pharm World Sci. 1999; 21:251-5.